Visteon (VC) Financials

Visteon logo
$81.30 +1.00 (+1.25%)
Closing price 11/19/2026 04:00 PM Eastern
Extended Trading
$81.26 -0.04 (-0.05%)
As of 07:38 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Visteon

Annual Income Statements for Visteon

This table shows Visteon's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
2,284 75 176 164 70 -56 41 124 568 296 201
Consolidated Net Income / (Loss)
2,328 91 192 174 81 -48 50 130 587 306 213
Net Income / (Loss) Continuing Operations
42 131 175 173 82 -48 50 130 587 306 213
Total Pre-Tax Income
69 161 223 216 106 -20 81 175 257 298 338
Total Operating Income
211 183 265 189 109 -15 83 166 275 292 322
Total Gross Profit
430 456 491 411 324 245 254 368 487 531 532
Total Revenue
3,245 3,161 3,146 2,984 2,945 2,548 2,773 3,756 3,954 3,866 3,768
Operating Revenue
3,245 3,161 3,146 2,984 2,945 2,548 2,773 3,756 3,954 3,866 3,768
Total Cost of Revenue
2,815 2,705 2,655 2,573 2,621 2,303 2,519 3,388 3,467 3,335 3,236
Operating Cost of Revenue
2,815 2,705 2,655 2,573 2,621 2,303 2,519 3,388 3,467 3,335 3,236
Total Operating Expenses
219 273 226 222 215 260 171 202 212 239 210
Selling, General & Admin Expense
245 224 226 193 221 193 175 188 207 207 202
Restructuring Charge
36 49 14 29 4.00 76 14 14 5.00 32 8.00
Total Other Income / (Expense), net
-142 -22 -42 27 -3.00 -5.00 -2.00 9.00 -18 6.00 16
Interest Expense
24 18 21 14 13 16 10 14 17 15 13
Interest & Investment Income
12 8.00 12 20 10 11 8.00 3.00 0.00 14 30
Other Income / (Expense), net
-130 -12 -33 21 - - - 20 -1.00 7.00 -1.00
Income Tax Expense
27 30 48 43 24 28 31 45 -330 -8.00 125
Net Income / (Loss) Attributable to Noncontrolling Interest
44 16 16 10 11 8.00 9.00 6.00 19 10 12
Basic Earnings per Share
$54.00 $2.14 $5.57 $5.56 $2.49 ($2.01) $1.46 $4.41 $20.21 $10.72 $7.39
Weighted Average Basic Shares Outstanding
42.30M 35M 31.60M 29.50M 28.02M 27.92M 28.00M 28.19M 27.49M 27.08M 26.82M
Diluted Earnings per Share
$52.63 $2.12 $5.47 $5.52 $2.48 ($2.01) $1.44 $4.35 $19.93 $10.61 $7.28
Weighted Average Diluted Shares Outstanding
42.30M 35M 31.60M 29.50M 28.02M 27.92M 28.00M 28.19M 27.49M 27.08M 26.82M
Weighted Average Basic & Diluted Shares Outstanding
42.30M 35M 31.60M 29.50M 28.02M 27.92M 28.00M 28.19M 27.49M 27.08M 26.82M
Cash Dividends to Common per Share
$43.40 $43.40 - - - - - - - - $0.38

Quarterly Income Statements for Visteon

This table shows Visteon's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
42 71 39 122 67 71 -11 14 31 49 5.00
Consolidated Net Income / (Loss)
44 75 40 125 69 75 -9.00 18 33 50 6.00
Net Income / (Loss) Continuing Operations
44 75 40 125 69 75 -9.00 18 33 50 6.00
Total Pre-Tax Income
63 100 51 84 95 97 81 65 49 76 7.00
Total Operating Income
65 97 52 78 91 92 75 64 41 73 1.00
Total Gross Profit
119 147 131 134 138 141 131 122 113 118 47
Total Revenue
933 1,014 980 939 934 969 917 948 954 960 970
Operating Revenue
933 1,014 980 939 934 969 917 948 954 960 970
Total Cost of Revenue
814 867 849 805 796 828 786 826 841 842 923
Operating Cost of Revenue
814 867 849 805 796 828 786 826 841 842 923
Total Operating Expenses
54 50 79 56 47 49 56 58 72 45 46
Selling, General & Admin Expense
52 49 51 55 47 48 53 54 54 46 46
Restructuring Charge
2.00 1.00 28 1.00 0.00 1.00 3.00 4.00 18 -1.00 0.00
Total Other Income / (Expense), net
-2.00 3.00 -1.00 6.00 4.00 5.00 6.00 1.00 8.00 3.00 6.00
Interest Expense
4.00 4.00 4.00 3.00 3.00 4.00 3.00 3.00 3.00 2.00 4.00
Interest & Investment Income
0.00 4.00 1.00 9.00 6.00 8.00 7.00 9.00 7.00 7.00 7.00
Other Income / (Expense), net
2.00 3.00 2.00 - 1.00 1.00 2.00 -5.00 4.00 -2.00 3.00
Income Tax Expense
19 25 11 -41 26 22 90 47 16 26 1.00
Net Income / (Loss) Attributable to Noncontrolling Interest
2.00 4.00 1.00 3.00 2.00 4.00 2.00 4.00 2.00 1.00 1.00
Basic Earnings per Share
$1.52 $2.57 $1.41 $4.43 $2.46 $2.60 ($0.40) $0.53 $1.16 $1.84 $0.20
Weighted Average Basic Shares Outstanding
27.60M 27.61M 27.62M 27.08M 27.26M 27.28M 27.29M 26.82M 26.69M 26.70M 24.71M
Diluted Earnings per Share
$1.50 $2.54 $1.40 $4.38 $2.44 $2.57 ($0.40) $0.52 $1.14 $1.80 $0.19
Weighted Average Diluted Shares Outstanding
27.60M 27.61M 27.62M 27.08M 27.26M 27.28M 27.29M 26.82M 26.69M 26.70M 24.71M
Weighted Average Basic & Diluted Shares Outstanding
27.60M 27.61M 27.62M 27.08M 27.26M 27.28M 27.29M 26.82M 26.69M 26.70M 24.71M

Annual Cash Flow Statements for Visteon

This table details how cash moves in and out of Visteon's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
1,902 -1,855 -173 -242 2.00 31 -45 68 -5.00 108 147
Net Cash From Operating Activities
338 116 215 204 183 168 58 167 267 427 410
Net Cash From Continuing Operating Activities
338 116 215 204 183 168 58 167 267 427 410
Net Income / (Loss) Continuing Operations
2,328 91 192 174 81 -48 50 130 587 306 213
Consolidated Net Income / (Loss)
2,328 91 192 174 81 -48 50 130 587 306 213
Depreciation Expense
169 84 87 91 100 104 108 108 104 96 109
Non-Cash Adjustments To Reconcile Net Income
-2,245 55 28 -10 19 20 53 34 43 58 49
Changes in Operating Assets and Liabilities, net
86 -114 -92 -51 -17 92 -153 -105 -467 -33 39
Net Cash From Investing Activities
2,358 302 -173 -98 -128 -98 -63 -68 -123 -189 -181
Net Cash From Continuing Investing Activities
2,358 302 -173 -98 -128 -98 -63 -68 -123 -189 -181
Purchase of Property, Plant & Equipment
-187 -75 -99 -127 -142 -104 -70 -81 -125 -137 -133
Acquisitions
-4.00 -25 -95 16 -3.00 -2.00 -5.00 0.00 0.00 -55 -50
Purchase of Investments
-47 47 - - - - - 0.00 0.00 -5.00 0.00
Other Investing Activities, net
-3.00 -18 6.00 13 11 0.00 8.00 1.00 2.00 8.00 2.00
Net Cash From Financing Activities
-774 -2,262 -234 -335 -49 -58 -29 -9.00 -156 -100 -116
Net Cash From Continuing Financing Activities
-774 -2,262 -234 -335 -49 -58 -29 -9.00 -156 -100 -116
Repayment of Debt
-249 -2.00 6.00 14 -20 -435 6.00 -357 -13 -18 -18
Repurchase of Common Equity
-500 -500 -200 -300 -20 -16 0.00 0.00 -106 -63 -57
Payment of Dividends
-55 -1,749 -39 -42 -9.00 -7.00 -35 -2.00 -29 -12 -36
Other Financing Activities, net
30 -11 -1.00 -7.00 - - 0.00 0.00 -8.00 -7.00 -5.00
Effect of Exchange Rate Changes
-20 -11 19 -13 -4.00 19 -11 -22 7.00 -30 34
Cash Interest Paid
24 14 16 15 14 18 15 14 16 14 12
Cash Income Taxes Paid
67 92 49 47 40 19 15 29 68 73 98

Quarterly Cash Flow Statements for Visteon

This table details how cash moves in and out of Visteon's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-7.00 1.00 45 73 32 -20 127 8.00 -91 -32 -184
Net Cash From Operating Activities
69 57 98 203 70 95 127 118 6.00 37 38
Net Cash From Continuing Operating Activities
61 57 98 203 70 95 127 118 6.00 37 38
Net Income / (Loss) Continuing Operations
44 75 40 125 69 69 59 18 33 50 6.00
Consolidated Net Income / (Loss)
44 75 40 125 69 69 59 18 33 50 6.00
Depreciation Expense
22 24 25 25 25 27 28 29 29 29 31
Non-Cash Adjustments To Reconcile Net Income
11 11 13 20 9.00 10 10 20 10 10 7.00
Changes in Operating Assets and Liabilities, net
-16 -53 20 33 -33 -11 30 51 -66 -52 -6.00
Net Cash From Investing Activities
-37 -35 -76 -41 -33 -82 -21 -45 -48 -45 -41
Net Cash From Continuing Investing Activities
-37 -35 -76 -41 -35 -82 -21 -45 -48 -45 -41
Purchase of Property, Plant & Equipment
- -31 -28 -41 -35 - - -45 -36 -25 -42
Purchase of Investments
- - - - 1.00 - - - -12 - 1.00
Net Cash From Financing Activities
-31 -5.00 -4.00 -60 -18 -20 -14 -64 -47 -30 -184
Net Cash From Continuing Financing Activities
-31 -5.00 -4.00 -60 -18 -20 -14 -64 -47 -30 -184
Repayment of Debt
- -5.00 -4.00 -5.00 -4.00 - - -5.00 -4.00 - -158
Repurchase of Common Equity
-20 - - -43 -7.00 - - -50 -30 -6.00 -200
Payment of Dividends
0.00 - - -12 -4.00 -14 -10 -8.00 -10 -19 -9.00
Other Financing Activities, net
-11 - - - -3.00 -10 9.00 -1.00 -3.00 -5.00 -6.00
Effect of Exchange Rate Changes
- -16 27 -29 13 - - -1.00 -2.00 6.00 3.00

Annual Balance Sheets for Visteon

This table presents Visteon's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
4,681 2,373 2,304 2,007 2,271 2,271 2,234 2,450 2,727 2,966 3,386
Total Current Assets
4,053 1,708 1,603 1,296 1,345 1,341 1,424 1,710 1,616 1,596 1,785
Cash & Equivalents
2,728 878 706 463 466 496 452 520 515 623 771
Restricted Cash
8.00 4.00 3.00 4.00 3.00 4.00 3.00 3.00 3.00 3.00 2.00
Accounts Receivable
502 505 530 486 514 484 549 672 666 578 613
Inventories, net
187 151 189 184 169 177 262 348 298 283 269
Other Current Assets
581 170 175 159 193 180 158 167 134 109 130
Plant, Property, & Equipment, net
351 345 377 397 0.00 0.00 0.00 0.00 0.00 0.00 524
Total Noncurrent Assets
277 320 324 314 926 930 810 740 1,111 1,370 1,077
Long-Term Investments
56 45 41 42 48 60 54 49 35 27 29
Goodwill
133 129 132 129 127 127 118 99 90 152 222
Noncurrent Deferred & Refundable Income Taxes
- - - - - - - 42 384 545 511
Other Noncurrent Operating Assets
88 146 151 143 751 743 638 550 602 646 315
Total Liabilities & Shareholders' Equity
4,681 2,373 2,304 2,007 2,271 2,271 2,234 2,450 2,727 2,966 3,386
Total Liabilities
3,482 1,649 1,543 1,425 1,676 1,761 1,618 1,676 1,604 1,552 1,735
Total Current Liabilities
2,772 911 801 721 798 824 852 1,035 931 916 992
Short-Term Debt
37 36 46 57 37 0.00 4.00 13 18 18 18
Accounts Payable
482 463 470 436 511 500 522 657 551 505 540
Current Employee Benefit Liabilities
132 103 105 67 73 83 80 90 99 107 122
Other Current Liabilities
370 309 180 161 177 241 246 275 263 286 312
Total Noncurrent Liabilities
710 738 742 704 878 937 766 641 673 636 743
Long-Term Debt
346 346 347 348 348 349 349 336 318 301 283
Capital Lease Obligations
- - - 0.00 139 146 - - 79 78 109
Noncurrent Deferred & Payable Income Tax Liabilities
21 20 23 23 27 28 27 27 31 43 51
Noncurrent Employee Benefit Liabilities
268 303 277 257 292 322 198 115 160 127 88
Other Noncurrent Operating Liabilities
75 69 95 76 72 92 192 163 85 87 212
Total Equity & Noncontrolling Interests
1,199 724 761 582 595 510 616 774 1,123 1,414 1,651
Total Preferred & Common Equity
1,057 586 637 465 480 387 516 675 1,038 1,333 1,568
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,057 586 637 465 480 387 516 675 1,038 1,333 1,568
Common Stock
1,346 1,328 1,340 1,336 1,343 1,349 1,350 1,353 1,357 1,377 1,399
Retained Earnings
1,194 1,269 1,445 1,609 1,679 1,623 1,664 1,788 2,274 2,652 2,838
Treasury Stock
-1,293 -1,778 -1,974 -2,264 -2,275 -2,281 -2,269 -2,253 -2,339 -2,390 -2,429
Accumulated Other Comprehensive Income / (Loss)
-190 -233 -174 -216 -267 -304 -229 -213 -254 -306 -240
Noncontrolling Interest
142 138 124 117 115 123 100 99 85 81 83

Quarterly Balance Sheets for Visteon

This table presents Visteon's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
2,321 2,357 2,739 2,731 2,893 2,997 3,192 3,254 3,423 3,456 3,401
Total Current Assets
1,597 1,622 1,630 1,641 1,702 1,697 1,723 1,778 1,821 1,802 1,695
Cash & Equivalents
455 481 504 505 550 655 668 762 680 648 464
Restricted Cash
4.00 4.00 3.00 3.00 3.00 3.00 3.00 3.00 2.00 2.00 2.00
Accounts Receivable
678 679 652 695 719 613 621 574 675 666 696
Inventories, net
329 318 342 311 321 310 296 313 316 328 359
Other Current Assets
131 140 129 127 109 116 135 126 148 158 174
Plant, Property, & Equipment, net
367 377 415 416 438 462 485 489 516 524 557
Total Noncurrent Assets
357 358 694 674 753 838 984 987 1,086 1,130 1,149
Long-Term Investments
37 36 30 25 27 29 25 27 31 25 29
Goodwill
88 83 87 84 157 153 224 224 216 233 239
Noncurrent Deferred & Refundable Income Taxes
- - 378 371 387 439 444 441 513 512 519
Other Noncurrent Operating Assets
232 239 199 194 182 217 291 295 326 360 362
Total Liabilities & Shareholders' Equity
2,321 2,357 2,739 2,731 2,893 2,997 3,192 3,254 3,423 3,456 3,401
Total Liabilities
1,543 1,556 1,605 1,533 1,620 1,600 1,694 1,692 1,781 1,767 1,904
Total Current Liabilities
911 948 938 887 937 927 921 941 1,053 1,015 1,056
Short-Term Debt
21 18 18 18 18 18 18 18 18 15 23
Accounts Payable
564 595 566 529 547 556 557 533 613 620 640
Current Employee Benefit Liabilities
74 86 84 81 98 90 88 111 98 85 91
Other Current Liabilities
252 249 270 259 274 263 258 279 324 295 302
Total Noncurrent Liabilities
632 608 667 646 683 673 773 751 728 752 848
Long-Term Debt
327 323 314 309 306 297 292 288 279 284 307
Capital Lease Obligations
93 87 89 83 79 112 111 115 115 111 106
Noncurrent Deferred & Payable Income Tax Liabilities
30 30 32 34 46 47 62 62 52 47 51
Noncurrent Employee Benefit Liabilities
109 104 156 149 143 125 115 105 83 80 76
Other Noncurrent Operating Liabilities
73 64 76 71 109 92 193 181 199 230 308
Total Equity & Noncontrolling Interests
778 801 1,134 1,198 1,273 1,397 1,498 1,562 1,642 1,689 1,497
Total Preferred & Common Equity
705 724 1,049 1,113 1,185 1,313 1,422 1,483 1,556 1,611 1,413
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
705 724 1,049 1,113 1,185 1,313 1,422 1,483 1,556 1,611 1,413
Common Stock
1,342 1,350 1,351 1,361 1,370 1,369 1,379 1,390 1,390 1,399 1,410
Retained Earnings
1,842 1,908 2,316 2,387 2,426 2,613 2,678 2,727 2,859 2,897 2,893
Treasury Stock
-2,266 -2,309 -2,350 -2,349 -2,348 -2,382 -2,380 -2,379 -2,441 -2,442 -2,642
Accumulated Other Comprehensive Income / (Loss)
-213 -225 -268 -286 -263 -287 -255 -255 -252 -243 -248
Noncontrolling Interest
73 77 85 85 88 84 76 79 86 78 84

Annual Metrics And Ratios for Visteon

This table displays calculated financial ratios and metrics derived from Visteon's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
25.48% -2.59% -0.47% -5.15% -1.31% -13.48% 8.83% 35.45% 5.27% -2.23% -2.53%
EBITDA Growth
-7.06% 2.00% 25.10% -5.64% -30.56% -57.42% 114.61% 53.93% 28.57% 4.50% 8.86%
EBIT Growth
8,200.00% 111.11% 35.67% -9.48% -48.10% -113.76% 653.33% 124.10% 47.31% 9.12% 7.36%
NOPAT Growth
18,447.83% 15.93% 39.66% -27.21% -44.30% -112.45% 587.95% 140.69% 338.21% -48.50% -32.32%
Net Income Growth
1,230.10% -96.09% 110.99% -9.38% -53.45% -159.26% 204.17% 160.00% 288.46% -43.76% -30.39%
EPS Growth
917.24% -95.97% 158.02% 0.91% -55.07% -181.05% 171.64% 202.08% 291.95% -42.40% -31.39%
Operating Cash Flow Growth
19.01% -65.68% 85.34% -5.12% -10.29% -8.20% -65.48% 187.93% 59.88% 59.93% -3.98%
Free Cash Flow Firm Growth
-112.08% 358.35% -103.67% 554.07% -151.28% 469.21% -75.27% -10.82% 229.17% 96.75% -19.65%
Invested Capital Growth
165.59% -63.77% 125.70% 18.32% 25.94% -26.08% 3.37% 19.78% 78.77% 7.01% 8.72%
Revenue Q/Q Growth
61.60% 0.22% -0.60% -2.16% 0.44% 1.72% -0.04% 7.99% -1.84% -1.30% 0.24%
EBITDA Q/Q Growth
-18.30% 87.50% 1.27% 2.03% 3.98% -16.04% 9.14% 8.89% 4.13% -0.25% -3.37%
EBIT Q/Q Growth
-13.83% 228.85% 0.43% 3.45% 5.83% -400.00% 29.69% 12.73% 7.45% -0.33% -5.59%
NOPAT Q/Q Growth
3,428.43% -18.33% 15.53% -9.28% 9.36% -400.00% 46.38% -5.14% 197.13% -47.51% -32.63%
Net Income Q/Q Growth
6.30% -16.51% 14.29% 9.43% -6.90% -65.52% 42.86% 0.00% 202.40% -46.62% -33.44%
EPS Q/Q Growth
9.74% -43.32% 15.64% 15.24% -10.47% -41.55% 44.00% 2.35% 216.33% -46.31% -34.65%
Operating Cash Flow Q/Q Growth
-10.58% 13.73% 3.86% 5.70% -14.88% 3.70% -1.69% 131.94% -20.06% 32.61% -17.17%
Free Cash Flow Firm Q/Q Growth
-110.35% 182.31% -117.94% 199.18% 20.47% 31.39% 64.70% 219.68% -30.41% 47.20% -50.57%
Invested Capital Q/Q Growth
100.81% -32.20% 15.76% -2.45% -2.43% -12.57% -11.88% -18.85% 39.12% -3.83% 5.71%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
13.25% 14.43% 15.61% 13.77% 11.00% 9.62% 9.16% 9.80% 12.32% 13.74% 14.12%
EBITDA Margin
7.70% 8.07% 10.14% 10.09% 7.10% 3.49% 6.89% 7.83% 9.56% 10.22% 11.41%
Operating Margin
6.50% 5.79% 8.42% 6.33% 3.70% -0.59% 2.99% 4.42% 6.96% 7.55% 8.55%
EBIT Margin
2.50% 5.41% 7.37% 7.04% 3.70% -0.59% 2.99% 4.95% 6.93% 7.73% 8.52%
Profit (Net Income) Margin
71.74% 2.88% 6.10% 5.83% 2.75% -1.88% 1.80% 3.46% 12.77% 7.35% 5.65%
Tax Burden Percent
3,373.91% 56.52% 86.10% 80.56% 76.42% 240.00% 61.73% 74.29% 196.50% 95.30% 63.02%
Interest Burden Percent
85.19% 94.15% 96.12% 102.86% 97.25% 133.33% 97.59% 94.09% 93.80% 99.67% 105.30%
Effective Tax Rate
39.13% 18.63% 21.52% 19.91% 22.64% 0.00% 38.27% 25.71% -96.50% 4.70% 36.98%
Return on Invested Capital (ROIC)
37.77% 44.25% 71.34% 34.33% 15.62% -2.01% 11.32% 24.39% 70.36% 27.30% 16.79%
ROIC Less NNEP Spread (ROIC-NNEP)
-150.22% 53.51% 74.88% 24.51% 22.46% 127.30% 12.44% 20.87% 89.96% 24.39% 13.68%
Return on Net Nonoperating Assets (RNNOA)
116.40% -34.79% -45.48% -8.41% -1.85% -6.68% -2.44% -5.69% -17.12% -3.95% -2.89%
Return on Equity (ROE)
154.17% 9.46% 25.86% 25.91% 13.76% -8.69% 8.88% 18.71% 53.24% 23.35% 13.90%
Cash Return on Invested Capital (CROIC)
-52.81% 137.86% -5.85% 17.55% -7.35% 27.98% 8.01% 6.39% 13.85% 20.53% 8.43%
Operating Return on Assets (OROA)
1.62% 4.85% 9.92% 9.74% 5.10% -0.66% 3.68% 7.94% 10.59% 10.70% 10.11%
Return on Assets (ROA)
46.54% 2.58% 8.21% 8.07% 3.79% -2.11% 2.22% 5.55% 19.51% 10.16% 6.71%
Return on Common Equity (ROCE)
98.12% 8.09% 21.30% 21.26% 11.05% -6.82% 7.12% 16.03% 48.08% 21.75% 13.16%
Return on Equity Simple (ROE_SIMPLE)
220.25% 15.53% 30.14% 37.42% 16.88% -12.40% 9.69% 19.26% 48.65% 23.11% 0.00%
Net Operating Profit after Tax (NOPAT)
128 149 208 151 84 -11 51 123 540 278 203
NOPAT Margin
3.96% 4.71% 6.61% 5.07% 2.86% -0.41% 1.85% 3.28% 13.67% 7.20% 5.39%
Net Nonoperating Expense Percent (NNEP)
188.00% -9.26% -3.54% 9.82% -6.85% -129.31% -1.12% 3.53% -19.60% 2.90% 3.11%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 10.98% 35.13% 16.30% 9.85%
Cost of Revenue to Revenue
86.75% 85.57% 84.39% 86.23% 89.00% 90.38% 90.84% 90.20% 87.68% 86.26% 85.88%
SG&A Expenses to Revenue
7.55% 7.09% 7.18% 6.47% 7.50% 7.57% 6.31% 5.01% 5.24% 5.35% 5.36%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
6.75% 8.64% 7.18% 7.44% 7.30% 10.20% 6.17% 5.38% 5.36% 6.18% 5.57%
Earnings before Interest and Taxes (EBIT)
81 171 232 210 109 -15 83 186 274 299 321
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
250 255 319 301 209 89 191 294 378 395 430
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.56 4.66 6.11 3.75 5.04 9.03 6.03 5.45 3.35 1.99 1.65
Price to Tangible Book Value (P/TBV)
2.93 5.98 7.71 5.19 6.86 13.44 7.82 6.39 3.66 2.28 1.93
Price to Revenue (P/Rev)
0.83 0.86 1.24 0.58 0.82 1.37 1.12 0.98 0.88 0.63 0.69
Price to Earnings (P/E)
1.19 36.43 22.11 10.63 34.59 0.00 75.89 29.69 7.15 8.94 12.91
Dividend Yield
0.00% 54.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.58%
Earnings Yield
84.36% 2.74% 4.52% 9.41% 2.89% 0.00% 1.32% 3.37% 13.99% 11.18% 7.75%
Enterprise Value to Invested Capital (EV/IC)
0.80 12.99 9.06 3.67 4.23 7.98 6.64 6.46 3.47 2.16 1.82
Enterprise Value to Revenue (EV/Rev)
0.12 0.74 1.16 0.59 0.86 1.39 1.10 0.95 0.87 0.59 0.61
Enterprise Value to EBITDA (EV/EBITDA)
1.57 9.12 11.47 5.83 12.17 39.91 16.00 12.10 9.05 5.76 5.32
Enterprise Value to EBIT (EV/EBIT)
4.86 13.60 15.77 8.36 23.34 0.00 36.81 19.13 12.48 7.61 7.12
Enterprise Value to NOPAT (EV/NOPAT)
3.06 15.62 17.59 11.60 30.16 0.00 59.64 28.85 6.33 8.18 11.27
Enterprise Value to Operating Cash Flow (EV/OCF)
1.16 20.05 17.02 8.61 13.90 21.14 52.68 21.30 12.81 5.33 5.58
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 5.01 0.00 22.69 0.00 24.24 84.33 110.10 32.16 10.87 22.43
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.32 0.53 0.52 0.70 0.88 0.97 0.57 0.45 0.37 0.30 0.25
Long-Term Debt to Equity
0.29 0.48 0.46 0.60 0.82 0.97 0.57 0.43 0.35 0.29 0.24
Financial Leverage
-0.77 -0.65 -0.61 -0.34 -0.08 -0.05 -0.20 -0.27 -0.19 -0.16 -0.21
Leverage Ratio
3.31 3.67 3.15 3.21 3.63 4.11 4.00 3.37 2.73 2.30 2.07
Compound Leverage Factor
2.82 3.45 3.03 3.30 3.53 5.48 3.90 3.17 2.56 2.29 2.18
Debt to Total Capital
24.21% 34.54% 34.06% 41.03% 46.83% 49.25% 36.43% 31.08% 26.98% 23.26% 19.89%
Short-Term Debt to Total Capital
2.34% 3.26% 3.99% 5.78% 3.31% 0.00% 0.41% 1.16% 1.17% 1.05% 0.87%
Long-Term Debt to Total Capital
21.87% 31.28% 30.07% 35.26% 43.52% 49.25% 36.02% 29.92% 25.81% 22.20% 19.02%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
8.98% 12.48% 10.75% 11.85% 10.28% 12.24% 10.32% 8.82% 5.53% 4.75% 4.03%
Common Equity to Total Capital
66.81% 52.98% 55.20% 47.11% 42.90% 38.51% 53.25% 60.11% 67.49% 72.00% 76.08%
Debt to EBITDA
1.53 1.50 1.23 1.35 2.51 5.56 1.85 1.19 1.10 1.01 0.95
Net Debt to EBITDA
-9.82 -2.14 -1.12 -0.35 0.03 -0.73 -0.82 -0.76 -0.37 -0.65 -0.91
Long-Term Debt to EBITDA
1.38 1.36 1.09 1.16 2.33 5.56 1.83 1.14 1.05 0.96 0.91
Debt to NOPAT
2.98 2.57 1.89 2.68 6.21 -47.14 6.89 2.83 0.77 1.43 2.02
Net Debt to NOPAT
-19.12 -3.66 -1.72 -0.69 0.08 6.19 -3.04 -1.81 -0.26 -0.92 -1.93
Long-Term Debt to NOPAT
2.69 2.32 1.67 2.30 5.78 -47.14 6.81 2.72 0.73 1.36 1.93
Altman Z-Score
1.90 3.72 4.51 4.03 3.65 3.56 3.87 4.45 4.55 4.17 3.78
Noncontrolling Interest Sharing Ratio
36.36% 14.56% 17.64% 17.94% 19.71% 21.54% 19.80% 14.32% 9.70% 6.82% 5.35%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.46 1.87 2.00 1.80 1.69 1.63 1.67 1.65 1.74 1.74 1.80
Quick Ratio
1.18 1.52 1.54 1.32 1.23 1.19 1.17 1.15 1.27 1.31 1.40
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-180 464 -17 77 -40 147 36 32 106 209 102
Operating Cash Flow to CapEx
180.75% 154.67% 217.17% 160.63% 128.87% 161.54% 82.86% 206.17% 213.60% 311.68% 308.27%
Free Cash Flow to Firm to Interest Expense
-7.48 25.77 -0.81 5.53 -3.05 9.16 3.62 2.31 6.26 13.95 7.84
Operating Cash Flow to Interest Expense
14.08 6.44 10.24 14.57 14.08 10.50 5.80 11.93 15.71 28.47 31.54
Operating Cash Flow Less CapEx to Interest Expense
6.29 2.28 5.52 5.50 3.15 4.00 -1.20 6.14 8.35 19.33 21.31
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.65 0.90 1.35 1.38 1.38 1.12 1.23 1.60 1.53 1.38 1.19
Accounts Receivable Turnover
6.28 6.28 6.08 5.87 5.89 5.11 5.37 6.15 5.91 6.22 6.33
Inventory Turnover
14.25 16.01 15.62 13.80 14.85 13.31 11.48 11.11 10.73 11.48 11.72
Fixed Asset Turnover
9.09 9.08 8.71 7.71 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
5.82 5.72 5.69 5.68 5.54 4.56 4.93 5.75 5.74 6.32 6.19
Days Sales Outstanding (DSO)
58.10 58.14 60.04 62.14 61.97 71.48 67.99 59.33 61.76 58.72 57.69
Days Inventory Outstanding (DIO)
25.61 22.80 23.37 26.46 24.58 27.42 31.81 32.86 34.00 31.79 31.13
Days Payable Outstanding (DPO)
62.69 63.76 64.13 64.26 65.94 80.12 74.04 63.51 63.59 57.79 58.93
Cash Conversion Cycle (CCC)
21.01 17.19 19.28 24.33 20.61 18.78 25.75 28.68 32.17 32.73 29.88
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
494 179 404 478 602 445 460 551 985 1,054 1,259
Invested Capital Turnover
9.54 9.39 10.79 6.77 5.45 4.87 6.13 7.43 5.15 3.79 3.12
Increase / (Decrease) in Invested Capital
308 -315 225 74 124 -157 15 91 434 69 101
Enterprise Value (EV)
394 2,326 3,659 1,756 2,544 3,552 3,056 3,558 3,421 2,275 2,286
Market Capitalization
2,708 2,733 3,892 1,743 2,422 3,494 3,112 3,682 3,474 2,450 2,595
Book Value per Share
$25.89 $17.23 $20.48 $16.08 $17.16 $13.90 $18.43 $23.98 $37.32 $44.50 $58.47
Tangible Book Value per Share
$22.63 $13.44 $16.24 $11.62 $12.62 $9.34 $14.22 $20.47 $34.09 $39.00 $50.19
Total Capital
1,582 1,106 1,154 987 1,119 1,005 969 1,123 1,538 1,707 2,061
Total Debt
383 382 393 405 524 495 353 349 415 397 410
Total Long-Term Debt
346 346 347 348 487 495 349 336 397 379 392
Net Debt
-2,456 -545 -357 -104 7.00 -65 -156 -223 -138 -256 -392
Capital Expenditures (CapEx)
187 75 99 127 142 104 70 81 125 137 133
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-1,465 -49 139 165 115 17 121 165 185 72 38
Debt-free Net Working Capital (DFNWC)
1,318 833 848 632 584 517 576 688 703 698 811
Net Working Capital (NWC)
1,281 797 802 575 547 517 572 675 685 680 793
Net Nonoperating Expense (NNE)
-2,200 58 16 -23 3.32 38 1.23 -6.69 35 -5.72 -10
Net Nonoperating Obligations (NNO)
-705 -545 -357 -104 7.00 -65 -156 -223 -138 -256 -392
Total Depreciation and Amortization (D&A)
169 84 87 91 100 104 108 108 104 96 109
Debt-free, Cash-free Net Working Capital to Revenue
-45.15% -1.55% 4.42% 5.53% 3.90% 0.67% 4.36% 4.39% 4.68% 1.86% 1.01%
Debt-free Net Working Capital to Revenue
40.62% 26.35% 26.95% 21.18% 19.83% 20.29% 20.77% 18.32% 17.78% 18.05% 21.52%
Net Working Capital to Revenue
39.48% 25.21% 25.49% 19.27% 18.57% 20.29% 20.63% 17.97% 17.32% 17.59% 21.05%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$54.00 $2.14 $5.57 $5.56 $2.49 ($2.01) $1.46 $4.41 $17.30 $9.93 $7.39
Adjusted Weighted Average Basic Shares Outstanding
38.86M 32.81M 30.92M 28.24M 28.02M 27.92M 28.00M 28.19M 27.49M 27.08M 26.82M
Adjusted Diluted Earnings per Share
$52.63 $2.12 $5.47 $5.52 $2.48 ($2.01) $1.44 $4.35 $17.05 $9.82 $7.28
Adjusted Weighted Average Diluted Shares Outstanding
38.86M 32.81M 30.92M 28.24M 28.02M 27.92M 28.00M 28.19M 27.49M 27.08M 26.82M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
38.86M 32.81M 30.92M 28.24M 28.02M 27.92M 28.00M 28.19M 27.49M 27.08M 26.82M
Normalized Net Operating Profit after Tax (NOPAT)
113 189 219 175 87 43 60 134 196 309 208
Normalized NOPAT Margin
3.47% 5.97% 6.96% 5.85% 2.97% 1.68% 2.16% 3.56% 4.96% 7.99% 5.52%
Pre Tax Income Margin
2.13% 5.09% 7.09% 7.24% 3.60% -0.78% 2.92% 4.66% 6.50% 7.71% 8.97%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
3.38 9.50 11.05 15.00 8.38 -0.94 8.30 13.29 16.12 19.93 24.69
NOPAT to Interest Expense
5.35 8.27 9.90 10.81 6.49 -0.66 5.12 8.81 31.79 18.55 15.61
EBIT Less CapEx to Interest Expense
-4.42 5.33 6.33 5.93 -2.54 -7.44 1.30 7.50 8.76 10.80 14.46
NOPAT Less CapEx to Interest Expense
-2.44 4.11 5.19 1.74 -4.44 -7.16 -1.88 3.02 24.43 9.42 5.38
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
2.36% 1,921.98% 20.31% 24.14% 11.11% -14.58% 70.00% 1.54% 5.74% 4.23% 16.90%
Augmented Payout Ratio
23.84% 2,471.43% 124.48% 196.55% 35.80% -47.92% 70.00% 1.54% 26.73% 26.41% 43.66%

Quarterly Metrics And Ratios for Visteon

This table displays calculated financial ratios and metrics derived from Visteon's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - - 26,819,486.00 26,694,021.00 26,695,429.00
DEI Adjusted Shares Outstanding
- - - - - - - - 26,819,486.00 26,694,021.00 26,695,429.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 1.16 1.84 0.19
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-3.52% 3.15% -3.35% -5.15% 0.11% -4.44% -6.43% 0.96% 2.14% -0.93% 5.78%
EBITDA Growth
0.00% 85.07% -33.05% -0.96% 31.46% -3.23% 32.91% -14.56% -36.75% -16.67% -66.67%
EBIT Growth
11.67% 143.90% -42.55% -1.27% 37.31% -7.00% 42.59% -24.36% -51.09% -23.66% -94.81%
NOPAT Growth
8.99% 123.27% -41.93% -68.47% 41.37% -10.04% 33.95% -87.02% -58.22% -32.48% 110.29%
Net Income Growth
15.79% 226.09% -43.66% -66.49% 52.27% -8.00% 47.50% -87.76% -52.17% -33.33% 166.67%
EPS Growth
27.12% 262.86% -39.66% -65.91% 57.33% -7.09% 45.71% -89.94% -53.28% -29.96% 147.50%
Operating Cash Flow Growth
463.16% -6.56% -22.83% 107.14% 1.45% 66.67% 29.59% -41.87% -91.43% -61.05% -70.08%
Free Cash Flow Firm Growth
-429.93% -5,101.49% -942.18% 171.49% 77.68% 70.44% 88.37% -128.16% -233.40% -99.01% -138.20%
Invested Capital Growth
40.03% 48.69% 54.80% 7.01% 11.69% 13.77% 8.67% 8.72% 17.94% 16.44% 20.74%
Revenue Q/Q Growth
-5.76% 8.68% -3.35% -4.18% -0.53% 3.75% -5.37% 3.38% 0.63% 0.63% 1.04%
EBITDA Q/Q Growth
-14.42% 39.33% -36.29% 30.38% 13.59% 2.56% -12.50% -16.19% -15.91% 35.14% -65.00%
EBIT Q/Q Growth
-15.19% 49.25% -46.00% 44.44% 17.95% 1.09% -17.20% -23.38% -23.73% 57.78% -94.37%
NOPAT Q/Q Growth
-87.67% 60.25% -43.94% 184.60% -44.71% 1.97% -16.52% -67.56% 55.80% 73.93% -98.22%
Net Income Q/Q Growth
-88.20% 70.45% -46.67% 212.50% -46.40% 2.99% -14.49% -69.49% 83.33% 51.52% -88.00%
EPS Q/Q Growth
-88.33% 69.33% -44.88% 212.86% -46.12% 0.00% -13.56% -74.51% 119.23% 57.89% -89.44%
Operating Cash Flow Q/Q Growth
-29.59% -17.39% 71.93% 107.14% -65.52% 35.71% 33.68% -7.09% -94.92% 516.67% 2.70%
Free Cash Flow Firm Q/Q Growth
-273.01% -13.70% -24.34% 113.56% -216.46% -50.59% 51.10% -106.28% -111.81% 13.27% -60.91%
Invested Capital Q/Q Growth
3.35% 5.60% 1.95% -3.83% 7.87% 7.56% -2.62% 5.71% 6.51% 6.19% 0.98%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
12.75% 14.50% 13.37% 14.27% 14.78% 14.55% 14.29% 12.87% 11.84% 12.29% 4.85%
EBITDA Margin
9.54% 12.23% 8.06% 10.97% 12.53% 12.38% 11.45% 9.28% 7.76% 10.42% 3.61%
Operating Margin
6.97% 9.57% 5.31% 8.31% 9.74% 9.49% 8.18% 6.75% 4.30% 7.60% 0.10%
EBIT Margin
7.18% 9.86% 5.51% 8.31% 9.85% 9.60% 8.40% 6.22% 4.72% 7.40% 0.41%
Profit (Net Income) Margin
4.72% 7.40% 4.08% 13.31% 7.17% 7.12% 6.43% 1.90% 3.46% 5.21% 0.62%
Tax Burden Percent
69.84% 75.00% 78.43% 148.81% 70.53% 71.13% 72.84% 27.69% 67.35% 65.79% 85.71%
Interest Burden Percent
94.03% 100.00% 94.44% 107.69% 103.26% 104.30% 105.19% 110.17% 108.89% 107.04% 175.00%
Effective Tax Rate
30.16% 25.00% 21.57% -48.81% 29.47% 28.87% 27.16% 72.31% 32.65% 34.21% 14.29%
Return on Invested Capital (ROIC)
21.86% 31.53% 18.07% 46.87% 24.66% 22.47% 19.58% 5.83% 8.85% 14.28% 0.26%
ROIC Less NNEP Spread (ROIC-NNEP)
23.29% 29.00% 18.65% 42.34% 23.16% 20.68% 17.99% 5.74% 6.93% 13.55% -2.13%
Return on Net Nonoperating Assets (RNNOA)
-2.35% -2.61% -2.43% -6.86% -3.44% -3.05% -3.48% -1.21% -1.28% -2.30% 0.30%
Return on Equity (ROE)
19.51% 28.92% 15.64% 40.02% 21.22% 19.41% 16.11% 4.61% 7.57% 11.99% 0.56%
Cash Return on Invested Capital (CROIC)
28.49% 22.90% 15.76% 20.53% 16.41% 12.19% 18.03% 8.43% -3.16% -4.47% -7.25%
Operating Return on Assets (OROA)
10.94% 15.43% 8.22% 11.49% 13.28% 12.39% 10.27% 7.38% 5.57% 8.41% 0.47%
Return on Assets (ROA)
7.19% 11.57% 6.09% 18.42% 9.67% 9.19% 7.87% 2.25% 4.08% 5.92% 0.71%
Return on Common Equity (ROCE)
17.78% 26.61% 14.40% 37.29% 19.80% 18.25% 15.16% 4.37% 7.15% 11.41% 0.53%
Return on Equity Simple (ROE_SIMPLE)
48.71% 50.58% 44.89% 0.00% 23.38% 21.17% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
45 73 41 116 64 65 55 18 28 48 0.86
NOPAT Margin
4.87% 7.17% 4.16% 12.36% 6.87% 6.75% 5.96% 1.87% 2.89% 5.00% 0.09%
Net Nonoperating Expense Percent (NNEP)
-1.43% 2.53% -0.58% 4.53% 1.50% 1.79% 1.60% 0.09% 1.92% 0.73% 2.39%
Return On Investment Capital (ROIC_SIMPLE)
- - - 6.80% 3.52% 3.41% 2.75% 0.86% 1.34% 2.29% 0.04%
Cost of Revenue to Revenue
87.25% 85.50% 86.63% 85.73% 85.22% 85.45% 85.71% 87.13% 88.16% 87.71% 95.15%
SG&A Expenses to Revenue
5.57% 4.83% 5.20% 5.86% 5.03% 4.95% 5.78% 5.70% 5.66% 4.79% 4.74%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
5.79% 4.93% 8.06% 5.96% 5.03% 5.06% 6.11% 6.12% 7.55% 4.69% 4.74%
Earnings before Interest and Taxes (EBIT)
67 100 54 78 92 93 77 59 45 71 4.00
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
89 124 79 103 117 120 105 88 74 100 35
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.12 2.65 2.22 1.99 1.60 1.79 2.20 1.65 1.57 1.64 1.64
Price to Tangible Book Value (P/TBV)
3.40 2.86 2.56 2.28 1.81 2.12 2.60 1.93 1.82 1.92 1.97
Price to Revenue (P/Rev)
0.83 0.75 0.67 0.63 0.54 0.67 0.87 0.69 0.65 0.70 0.60
Price to Earnings (P/E)
6.62 5.40 5.08 8.94 7.08 8.74 10.58 12.91 14.81 18.52 14.55
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.23% 0.58% 1.02% 1.31% 1.62%
Earnings Yield
15.10% 18.51% 19.70% 11.18% 14.13% 11.44% 9.45% 7.75% 6.75% 5.40% 6.87%
Enterprise Value to Invested Capital (EV/IC)
3.18 2.70 2.32 2.16 1.69 1.92 2.50 1.82 1.66 1.73 1.63
Enterprise Value to Revenue (EV/Rev)
0.83 0.74 0.65 0.59 0.50 0.61 0.79 0.61 0.59 0.65 0.61
Enterprise Value to EBITDA (EV/EBITDA)
8.57 6.68 6.41 5.76 4.55 5.59 6.69 5.32 5.76 6.71 7.88
Enterprise Value to EBIT (EV/EBIT)
11.53 8.55 8.47 7.61 5.94 7.39 8.76 7.12 8.13 9.77 13.07
Enterprise Value to NOPAT (EV/NOPAT)
6.00 5.21 4.79 8.18 6.51 8.14 9.89 11.27 13.52 17.34 15.41
Enterprise Value to Operating Cash Flow (EV/OCF)
9.13 8.28 7.89 5.33 4.50 5.03 6.01 5.58 6.44 8.55 11.75
Enterprise Value to Free Cash Flow (EV/FCFF)
13.03 14.12 17.87 10.87 10.89 16.73 14.44 22.43 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.37 0.34 0.32 0.30 0.31 0.28 0.27 0.25 0.25 0.24 0.29
Long-Term Debt to Equity
0.36 0.33 0.30 0.29 0.29 0.27 0.26 0.24 0.24 0.23 0.28
Financial Leverage
-0.10 -0.09 -0.13 -0.16 -0.15 -0.15 -0.19 -0.21 -0.18 -0.17 -0.14
Leverage Ratio
2.65 2.56 2.53 2.30 2.27 2.20 2.17 2.07 2.11 2.09 2.18
Compound Leverage Factor
2.49 2.56 2.39 2.47 2.34 2.29 2.28 2.28 2.30 2.23 3.81
Debt to Total Capital
27.07% 25.50% 24.05% 23.26% 23.41% 21.94% 21.23% 19.89% 20.06% 19.53% 22.56%
Short-Term Debt to Total Capital
1.16% 1.12% 1.07% 1.05% 0.99% 0.94% 0.91% 0.87% 0.88% 0.71% 1.19%
Long-Term Debt to Total Capital
25.92% 24.38% 22.97% 22.20% 22.42% 21.00% 20.32% 19.02% 19.18% 18.82% 21.37%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
5.47% 5.29% 5.25% 4.75% 4.61% 3.96% 3.98% 4.03% 4.19% 3.72% 4.35%
Common Equity to Total Capital
67.46% 69.22% 70.70% 72.00% 71.98% 74.10% 74.79% 76.08% 75.75% 76.75% 73.10%
Debt to EBITDA
1.11 0.94 1.02 1.01 1.01 1.00 0.95 0.95 1.06 1.12 1.47
Net Debt to EBITDA
-0.31 -0.28 -0.45 -0.65 -0.61 -0.66 -0.83 -0.91 -0.78 -0.72 -0.20
Long-Term Debt to EBITDA
1.07 0.90 0.97 0.96 0.97 0.96 0.91 0.91 1.02 1.08 1.39
Debt to NOPAT
0.78 0.73 0.76 1.43 1.44 1.46 1.40 2.02 2.50 2.89 2.87
Net Debt to NOPAT
-0.22 -0.22 -0.33 -0.92 -0.88 -0.95 -1.23 -1.93 -1.83 -1.87 -0.39
Long-Term Debt to NOPAT
0.75 0.70 0.73 1.36 1.38 1.40 1.34 1.93 2.39 2.78 2.72
Altman Z-Score
4.22 4.28 3.88 3.92 3.71 3.67 3.87 3.52 3.41 3.51 3.28
Noncontrolling Interest Sharing Ratio
8.86% 8.00% 7.96% 6.82% 6.68% 5.97% 5.89% 5.35% 5.59% 4.83% 5.33%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.74 1.85 1.82 1.74 1.83 1.87 1.89 1.80 1.73 1.78 1.61
Quick Ratio
1.23 1.35 1.35 1.31 1.37 1.40 1.42 1.40 1.29 1.29 1.10
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-246 -279 -347 47 -55 -83 -40 -83 -176 -153 -246
Operating Cash Flow to CapEx
186.49% 183.87% 350.00% 495.12% 200.00% 0.00% 0.00% 262.22% 16.67% 148.00% 90.48%
Free Cash Flow to Firm to Interest Expense
-61.40 -69.81 -86.80 15.69 -18.27 -20.64 -13.46 -27.76 -58.80 -76.49 -61.54
Operating Cash Flow to Interest Expense
17.25 14.25 24.50 67.67 23.33 23.75 42.33 39.33 2.00 18.50 9.50
Operating Cash Flow Less CapEx to Interest Expense
8.00 6.50 17.50 54.00 11.67 23.75 42.33 24.33 -10.00 6.00 -1.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.52 1.56 1.49 1.38 1.35 1.29 1.22 1.19 1.18 1.14 1.15
Accounts Receivable Turnover
5.82 5.76 5.60 6.22 6.11 5.81 5.81 6.33 5.88 5.87 6.03
Inventory Turnover
9.78 10.66 10.61 11.48 10.17 10.80 10.14 11.72 10.48 10.56 10.21
Fixed Asset Turnover
10.05 10.09 9.61 0.00 8.82 8.48 8.11 0.00 7.75 7.49 7.33
Accounts Payable Turnover
5.85 6.24 5.94 6.32 5.91 6.04 5.95 6.19 5.61 5.60 5.85
Days Sales Outstanding (DSO)
62.71 63.42 65.14 58.72 59.70 62.84 62.78 57.69 62.05 62.15 60.48
Days Inventory Outstanding (DIO)
37.31 34.23 34.40 31.79 35.87 33.79 35.99 31.13 34.82 34.56 35.73
Days Payable Outstanding (DPO)
62.41 58.46 61.48 57.79 61.73 60.46 61.31 58.93 65.02 65.19 62.38
Cash Conversion Cycle (CCC)
37.61 39.19 38.06 32.73 33.84 36.17 37.46 29.88 31.85 31.52 33.84
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,018 1,075 1,096 1,054 1,137 1,223 1,191 1,259 1,341 1,424 1,438
Invested Capital Turnover
4.49 4.39 4.34 3.79 3.59 3.33 3.29 3.12 3.06 2.86 2.92
Increase / (Decrease) in Invested Capital
291 352 388 69 119 148 95 101 204 201 247
Enterprise Value (EV)
3,240 2,907 2,540 2,275 1,926 2,344 2,977 2,286 2,229 2,461 2,339
Market Capitalization
3,271 2,945 2,629 2,450 2,102 2,543 3,269 2,595 2,444 2,648 2,314
Book Value per Share
$38.01 $40.33 $42.92 $44.50 $48.49 $52.17 $54.37 $58.47 $58.02 $60.35 $52.93
Tangible Book Value per Share
$34.86 $37.29 $37.24 $39.00 $42.84 $43.95 $46.16 $50.19 $49.96 $51.62 $43.98
Total Capital
1,555 1,608 1,676 1,707 1,824 1,919 1,983 2,061 2,054 2,099 1,933
Total Debt
421 410 403 397 427 421 421 410 412 410 436
Total Long-Term Debt
403 392 385 379 409 403 403 392 394 395 413
Net Debt
-116 -123 -177 -256 -260 -275 -371 -392 -301 -265 -59
Capital Expenditures (CapEx)
37 31 28 41 35 0.00 0.00 45 36 25 42
Debt-free, Cash-free Net Working Capital (DFCFNWC)
203 264 230 72 130 149 90 38 104 152 196
Debt-free Net Working Capital (DFNWC)
710 772 783 698 788 820 855 811 786 802 662
Net Working Capital (NWC)
692 754 765 680 770 802 837 793 768 787 639
Net Nonoperating Expense (NNE)
1.40 -2.25 0.78 -8.93 -2.82 -3.56 -4.37 -0.28 -5.39 -1.97 -5.14
Net Nonoperating Obligations (NNO)
-116 -123 -177 -256 -260 -275 -371 -392 -301 -265 -59
Total Depreciation and Amortization (D&A)
22 24 25 25 25 27 28 29 29 29 31
Debt-free, Cash-free Net Working Capital to Revenue
5.18% 6.68% 5.87% 1.86% 3.36% 3.90% 2.39% 1.01% 2.75% 4.02% 5.11%
Debt-free Net Working Capital to Revenue
18.11% 19.54% 19.99% 18.05% 20.38% 21.45% 22.75% 21.52% 20.75% 21.22% 17.28%
Net Working Capital to Revenue
17.65% 19.08% 19.53% 17.59% 19.91% 20.98% 22.27% 21.05% 20.27% 20.83% 16.68%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.52 $2.57 $1.41 $4.43 $2.39 $2.38 $2.09 $0.53 $1.16 $1.84 $0.20
Adjusted Weighted Average Basic Shares Outstanding
27.60M 27.61M 27.62M 27.08M 27.26M 27.28M 27.29M 26.82M 26.69M 26.70M 24.71M
Adjusted Diluted Earnings per Share
$1.50 $2.54 $1.40 $4.38 $2.36 $2.36 $2.04 $0.52 $1.14 $1.80 $0.19
Adjusted Weighted Average Diluted Shares Outstanding
27.60M 27.61M 27.62M 27.08M 27.26M 27.28M 27.29M 26.82M 26.69M 26.70M 24.71M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
27.60M 27.61M 27.62M 27.08M 27.26M 27.28M 27.29M 26.82M 26.69M 26.70M 24.71M
Normalized Net Operating Profit after Tax (NOPAT)
47 74 63 55 64 66 57 48 40 47 0.86
Normalized NOPAT Margin
5.02% 7.25% 6.40% 5.89% 6.87% 6.83% 6.20% 5.02% 4.17% 4.93% 0.09%
Pre Tax Income Margin
6.75% 9.86% 5.20% 8.95% 10.17% 10.01% 8.83% 6.86% 5.14% 7.92% 0.72%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
16.75 25.00 13.50 26.00 30.67 23.25 25.67 19.67 15.00 35.50 1.00
NOPAT to Interest Expense
11.35 18.19 10.20 38.69 21.39 16.36 18.21 5.91 9.20 24.01 0.21
EBIT Less CapEx to Interest Expense
7.50 17.25 6.50 12.33 19.00 23.25 25.67 4.67 3.00 23.00 -9.50
NOPAT Less CapEx to Interest Expense
2.10 10.44 3.20 25.02 9.73 16.36 18.21 -9.09 -2.80 11.51 -10.29
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
4.11% 2.49% 0.38% 4.23% 5.21% 9.97% 12.50% 16.90% 23.73% 30.92% 27.54%
Augmented Payout Ratio
28.77% 19.54% 9.77% 26.41% 21.50% 26.58% 28.13% 43.66% 68.93% 87.50% 198.80%

Financials Breakdown Chart

Key Financial Trends

Visteon’s second-quarter 2026 results show a meaningful sequential recovery, but year-over-year profitability remains below the prior year. Revenue rose to $960 million from $954 million in Q1 2026 and $917 million in Q3 2025. However, revenue was slightly below the restated $969 million reported in Q2 2025.

Profitability improved from the first quarter: operating income increased to $73 million from $41 million, while net income attributable to common shareholders rose to $49 million from $31 million. Diluted EPS increased to $1.80 from $1.14. The improvement was helped by lower selling, general and administrative costs and the absence of a significant restructuring charge in Q2.

Despite the sequential rebound, margins weakened compared with Q2 2025. Gross margin declined to approximately 12.3% from 14.6%, operating margin fell to 7.6% from 9.5%, and diluted EPS dropped from $2.57. This indicates that higher revenue and lower operating expenses have not fully offset pressure in the company’s cost of revenue.

  • Sequential earnings recovery: Operating income rose 78% from Q1 2026, and net income attributable to common shareholders increased 58%.
  • Cost-control benefit: SG&A declined to $46 million from $54 million in Q1, while the $1 million restructuring benefit helped reduce total operating expenses to $45 million.
  • Share count continues to decline: Weighted average diluted shares fell to 26.7 million from 27.3 million in Q2 2025, supporting per-share results. The company also repurchased $6 million of stock during Q2 2026.
  • Solid liquidity position: Visteon held $648 million of cash and equivalents at June 30, 2026, compared with approximately $410 million of total debt and capital lease obligations.
  • Balance-sheet expansion: Total equity and noncontrolling interests increased to $1.689 billion from $1.498 billion in Q2 2025, while total liabilities rose more modestly.
  • Operating cash flow remains positive but volatile: Q2 operating cash flow was $37 million, an improvement from $6 million in Q1 2026 but well below $95 million in Q2 2025 and $118 million in Q4 2025.
  • Capital spending is continuing: Visteon spent $25 million on property, plant and equipment in Q2, producing approximately $12 million of cash flow after capital expenditures.
  • Year-over-year margin deterioration: Gross profit fell to $118 million from $141 million in Q2 2025, and operating income declined 21% from $92 million.
  • Working capital consumed cash: Changes in operating assets and liabilities reduced Q2 operating cash flow by $52 million, suggesting continued pressure from receivables, inventory or supplier payments.
  • Cash balance is trending lower: Cash and equivalents declined from $762 million in Q3 2025 and $680 million in Q1 2026 to $648 million at the end of Q2. Financing outflows, including $19 million of dividends, contributed to a $32 million quarterly decline in cash.

For investors, the latest quarter presents a mixed picture. Visteon’s sequential earnings recovery, lower share count and manageable leverage are constructive. However, the company still faces weaker year-over-year margins and inconsistent cash generation. The key issue to monitor is whether the Q2 operating-income rebound can continue without relying primarily on expense reductions, while working-capital management and cash conversion improve.

11/20/26 08:05 AM ETAI Generated. May Contain Errors.

Visteon Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Visteon's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Visteon's net income appears to be on a downward trend, with a most recent value of $213 million in 2025, falling from $2.33 billion in 2015. The previous period was $306 million in 2024. Find out what analysts predict for Visteon in the coming months.

Visteon's total operating income in 2025 was $322 million, based on the following breakdown:
  • Total Gross Profit: $532 million
  • Total Operating Expenses: $210 million

Over the last 10 years, Visteon's total revenue changed from $3.25 billion in 2015 to $3.77 billion in 2025, a change of 16.1%.

In the past 13 quarters, Visteon's cash and equivalents has ranged from $455 million in Q2 2023 to $762 million in Q3 2025, and is currently $464 million as of their latest financial filing in Q3 2026.

Visteon had total debt of $410 million at the end of 2025, a 3.3% increase from 2024, and a 7.0% increase since 2015.

Over the last 10 years, Visteon's book value per share changed from 25.89 in 2015 to 58.47 in 2025, a change of 125.8%.



Financial statements for NASDAQ:VC last updated on 10/22/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners